<?xml version="1.0" encoding="UTF-8"?>
<p>The aim of this study was to determine the efficacy and safety of TMZ monotherapy in patients with unresectable EPNEC resistant to platinum‚Äêbased chemotherapy. Evaluation of the expression of MGMT, a chemosensitivity marker of TMZ, was also undertaken as an additional study.</p>
